EnerSyn Global Inc. (ESYN)
NASDAQ: ESYNHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ESYN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $37.44M
- EPS (TTM)
- -$0.58
- Dividend yield
- None
- 52-week range
- 0.88 – 2.81
- Day range
- 1.05 – 1.17
- Volume / Avg
- 9.72K / 38.17K
- Beta
- —
- Shares outstanding
- 33.73M
52-week range
ESYN stock today
Shares of EnerSyn Global (ESYN) finished lower on Nov 20 at $1.11, a drop of 0.89% or $0.01 per share, versus the S&P 500's 3.70% decline. Trading was light, with 9.72K shares changing hands, about 25% of the average daily volume. Shares are 60.5% below their 52-week high of $2.81, set on Dec 8, 2025 and 26.1% above the 52-week low of $0.88, near the bottom of the past year's range.
ESYN is down 25.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 26.5%. EnerSyn Global has posted a net loss over the last twelve months (EPS of -$0.58), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About EnerSyn Global
Company profileEnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea. The company provides Hapi Café, a health-focused dining destination offering a various nutritious meal, including Keto and plant-based options; Hapi Marketplace, a business-to-consumer platform featuring diverse product categories; and Hapi Wealth Builder, an educational program focused on wealth-building strategies; and provides participants the opportunity to attend courses, workshops, and coaching sessions in person fostering a collaborative learning environment for those dedicated to learning about investment in equities and wealth-building strategies.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Dr. Ming Xing Liu
- Headquarters
- Bethesda, MD
- Employees
- 4
- IPO year
- 2022
- Website
- hwhintl.com
Financial highlights
Full financialsIn fiscal 2025, EnerSyn Global generated $866,926 in revenue, down 30.8% from fiscal 2024, the first decline in the 5 years shown. EnerSyn Global reported a net loss of $2.6 million, compared with a loss of $2.7 million a year earlier. Gross margin was 53.0% (up from 48.0%).
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $866.93K | $1.25M | $1.18K | — | — |
| Growth | -30.84% | +105776.44% | — | — | — |
| Net income | $-2.63M | $-2.75M | $-1.08M | $548.87K | $113.54K |
| EPS (diluted) | $-0.40 | $-0.76 | — | — | — |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $-0.15 vs —
EnerSyn Global peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COSMCosmos Health Inc. | 2.81 | -2.09% | $14.14M | vs ESYN |
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs ESYN |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs ESYN |
| NUSNu Skin Enterprises Inc. | 3.80 | +0.80% | $184.98M | vs ESYN |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs ESYN |
| CAHCardinal Health Inc. | 272.81 | +0.17% | $63.06B | vs ESYN |
| CORCencora Inc. | 339.09 | -0.63% | $64.71B | vs ESYN |
| MCKMcKesson Corporation | 1,069.43 | +0.68% | $123.47B | vs ESYN |
Indexes, lists and sector
EnerSyn Global stock FAQ
What is EnerSyn Global's stock price today?
ESYN last traded at $1.11 as of Nov 20, 4:00 PM EST, down 0.89% on the day. Prices are delayed at least 15 minutes.
Does EnerSyn Global pay a dividend?
No. EnerSyn Global does not currently pay a regular cash dividend.
Who is EnerSyn Global's CEO?
Dr. Ming Xing Liu is the chief executive officer of EnerSyn Global Inc., which has about 4 employees.
Has ESYN ever split its stock?
Yes. The most recent ESYN stock split was a 1-for-5 split on Feb 24, 2025.
What is the ESYN 52-week high?
The 52-week high for ESYN is $2.81 and the 52-week low is $0.88. The stock is currently 60.5% below its high.